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Interlinked gene regulatory networks (GRNs) are vital for the spatial and temporal control of gene
expression during development. The hematopoietic transcription factors (TFs) Scl, Gata2 and Fli1 form
one such densely connected GRN which acts as a master regulator of embryonic hematopoiesis. This triad
has been shown to direct the speciﬁcation of the hemogenic endothelium and emergence of
hematopoietic stem cells (HSCs) in response to Notch1 and Bmp4–Smad signaling. Here we employ
previously published data to construct a mathematical model of this GRN network and use this model to
systematically investigate the network dynamical properties. Our model uses a statistical-
thermodynamic framework to describe the combinatorial regulation of gene expression and reconciles,
mechanistically, several previously published but unexplained results from different genetic perturbation
experiments. In particular, our results demonstrate how the interactions of Runx1, an essential
hematopoietic TF, with components of the Bmp4 signaling pathway allow it to affect triad activation
and acts as a key regulator of HSC emergence. We also explain why heterozygous deletion of this
essential TF, Runx1, speeds up the network dynamics leading to accelerated HSC emergence. Taken
together our results demonstrate that the triad, a master-level controller of deﬁnitive hematopoiesis, is
an irreversible bistable switch whose dynamical properties are modulated by Runx1 and components of
the Bmp4 signaling pathway.
& 2013 Elsevier Inc. All rights reserved.Introduction
Hematopoietic stem cells (HSCs) are a rare population of cells
with self-renewal potential to divide and contribute cells to all
blood lineages throughout the life of an organism. The ontogeny of
HSCs has been carefully studied in terms of anatomical locations
and stages of cellular progression (Medvinsky et al., 2011; Orkin
and Zon, 2008). Studies using mouse, zebraﬁsh and embryonic
stem cells have demonstrated that blood progenitor cells (with
limited self-renewal ability) are formed early during embryogen-
esis, initially in the yolk sac and then in the embryo (Medvinsky
et al., 2011). This is followed by the emergence of deﬁnitive
HSCs (with long-term self-renewal potential) initially in the
aorta-gonads-mesonephros region of both mice and humans
(Medvinsky et al., 2011). Furthermore, it has been shown that a
specialized part of the blood vessel network termed the ‘hemo-
genic endothelium’ undergoes an endothelial-to-hematopoieticll rights reserved.
anda),transition (EHT) to form blood stem/progenitor cells (Bertrand
et al., 2010; Boisset et al., 2010; Eilken et al., 2009; Lancrin et al.,
2009; Zovein et al., 2008). Understanding the molecular mechan-
isms that drive HSC and blood formation in the developing
embryo will be crucial in designing novel regenerative medicine
protocols.
Tight spatial and temporal control of gene expression is vital for
the proper development of an organism (Davidson, 2006). Gene
expression programs are coordinately regulated by the combina-
torial binding of tissue-speciﬁc transcription factors (TFs) and
external cues that are communicated to cells via signaling path-
ways. Several TFs regulating key stages of blood cell development
have been identiﬁed (Marks-Bluth and Pimanda, 2012). Scl, Gata2
and Fli1 act early during development to specify the hemogenic
endothelium and are necessary for HSC emergence (Hart et al.,
2000; Ling et al., 2004; Schlaeger et al., 2005; Shivdasani et al.,
1995; Tsai et al., 1994). On the other hand, Runx1 is required in the
hemogenic endothelium for the EHT but not subsequently (Chen
et al., 2009; Li et al., 2006; Liakhovitskaia et al., 2009). TF activities
and signaling pathways are integrated by cis-regulatory modules
such as promoters and enhancers which have been characterized
for numerous TFs involved in HSC emergence (Pimanda and
Gottgens, 2010). Enhancers for Gata2, Fli1 and Scl are bound by
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(Pimanda et al., 2007b), and the HSC enhancer for Runx1 is bound
by all three triad proteins (Nottingham et al., 2007).
Two signaling pathways, Bmp and Notch, are required for HSC
and progenitor development (Durand et al., 2007; Kaimakis et al.,
2013; Kumano et al., 2003; Marks-Bluth and Pimanda, 2012). The
Notch1 intracellular mediator binds at the Gata2 locus, whereas
Bmp-induced signaling mediator, Smad1, binds at the Runx1
promoter and at the Gata2 and Fli1 enhancers (Fig. 1A; (Oren
et al., 2005; Pimanda et al., 2007a; Robert-Moreno et al., 2005)).
Smad6, an inhibitory Smad, participates in the Bmp4-signaling
pathway by hindering Smad1 activation and targeting it for
proteolytic degradation (Knezevic et al., 2011). The Smad6 enhan-
cer is bound by the triad proteins, Smad1 and Runx1, and a
negative feedback loop from Smad6 regulates Runx1 by promoting
its proteosomal degradation (Knezevic et al., 2011). Runx1 binding
at the Smad6 enhancer is mediated by triad TFs, thus triad
activation temporally balances Runx1 activity by up-regulating
both Runx1 and its negative regulator Smad6 (Knezevic et al.,
2011). Altogether these interactions form a gene regulatory net-
work (GRN) that controls hematopoietic stem and progenitor cell
emergence in the developing embryo (Fig. 1B). Multiple feed-
forward and feedback loops present in the GRN (Fig. 1A) lead to
complex dynamical properties that allow tight control over the
network's response to external and internal cues. Understanding
these complex emergent properties with purely experimental
approaches is challenging; mathematical modeling of networks
can serve as an important complementary approach. Models can
combine qualitative and quantitative information about network
architecture and parameters, and thereby serve as an integrative
platform for understanding the results of various genetic pertur-
bations and for making novel predictions.
In this study, we build a mathematical model of the GRN shown
in Fig. 1B based on previously published details of cis-regulatoryFli1 Gata2Scl
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Fig. 1. GRN responsible for regulating HSC speciﬁcation. (A) The GRN responsible
for regulating HSC cell speciﬁcation contains TFs Scl, Gata2, and Fli1 that are
connected via multiple positive feedback loops (dashed box). This triad is regulated
directly via Notch1 and indirectly via Bmp4 through a peripheral circuit containing
Smad1, Smad6, and Runx1. Bmp4 affects the triad indirectly by regulating the
Smad1 phosphorylation rate. Smad6 negatively regulates pSmad1 and Runx1
(blunted arrows) by targeting them for proteasomal degradation. Arrows represent
positive transcriptional regulation. (B) Detailed representation of the regulatory
connections in the GRN that explicitly shows the various promoters and binding
sites (using the notation from (8)). The top half of the diagram shows the triad
module, whereas the bottom half shows the signaling module.modules, TF-binding and protein–protein interactions. The model
integrates Runx1 regulation as well as Bmp4 and Notch1 signaling
with the Scl–Gata2–Fli1 triad module. Using this model we
elucidate the role of Runx1 in the network. Dynamical properties
of the network predicted by the model are in good agreement with
in vitro and in vivo experimental observations. Moreover, in silico
perturbations of Runx1, Notch1 and Bmp4 in the simulations
closely match the observations in knockout and over-expression
phenotypes. Importantly, our model provides mechanistic insight
into the early emergence of blood progenitors observed in Runx1
haploid embryos. Taken together these results suggest that the
GRN analyzed here can act as a master-level switch in the signal
pathway controlling deﬁnitive hematopoiesis.Results
Notch1 is necessary for irreversible activation of the triad
Deﬁnitive hematopoiesis is the production of blood progenitor
cells with the potential to form mature erythroid and myeloid
cells, and occurs in multiple sites of the developing embryo
including the yolk sac, placenta, AGM and head regions (Li et al.,
2012; Lux et al., 2008; Medvinsky and Dzierzak, 1996; Rhodes
et al., 2008). The Scl–Gata2–Fli1 triad (Fig. 1A, dashed box) is at the
core of the GRN analyzed here; its activation with Notch1 and
Bmp4 signals is known to play an important role in deﬁnitive
hematopoiesis (Durand et al., 2007; Kataoka et al., 2011; Pimanda
et al., 2007b; Wareing et al., 2012). Previously, we used a
mathematical model to show that Notch1 and Bmp4 cause an
irreversible switch to high levels of triad gene expression and
thereby explained their role in the activation of these master
regulatory genes of deﬁnitive hematopoiesis (Narula et al., 2010).
Here we extend this model to incorporate recently uncovered
interactions between components of the Bmp4 signaling pathway
and Runx1, another key regulator of deﬁnitive hematopoiesis
(Knezevic et al., 2011; Pimanda et al., 2007a).
In this extended model we explicitly include the components
involved in Bmp4 signaling—Smad1, Smad6 and Runx1. We brieﬂy
outline the major interactions and assumptions of the model (see
the “Methods” section and SI for details). Bmp4 promotes the
phosphorylation of Smad1, following which pSmad1 translocates
to the nucleus and upregulates the transcription of the triad genes
as well as of Runx1 and Smad6 (Attisano and Wrana, 2002; Bee
et al., 2009a; Ishida et al., 2000). Runx1 forms a complex with
pSmad1 in the nucleus (Zaidi et al., 2002). We assume that the
formation of this complex enhances the effect of pSmad1 on triad
gene expression although it is not essential for triad upregulation.
As a result, in our model, Runx1 participates in triad regulation but
is not essential for triad gene expression. Smad6 post-
translationally modulates Bmp4 signaling by forming complexes
with Runx1 and pSmad1, and thereby targeting them for proteo-
lytic degradation (Knezevic et al., 2011; Murakami et al., 2003). In
addition the triad feeds back to the signaling module by tran-
scriptionally upregulating Runx1, Smad6 and Smad1 (see the
“Methods” and Fig. S1; (Bee et al., 2009a, 2009b; Knezevic et al.,
2011; Nottingham et al., 2007; Pimanda et al., 2007b)). It should be
noted that our model focuses speciﬁcally on the emergence of
HSCs from the hemogenic endothelium and as such cannot be
used to infer the effects of either Bmp4 and Notch1 signals or triad
gene expression levels on the eventual fate (i.e. differentiation
and/or proliferation potential) of these cells.
To understand the role of the Smad1–Smad6–Runx1 signaling
module we ﬁrst examine the steady-state response of the network
to Notch1 and Bmp4 signals. To this end we compute how the
steady-state concentrations of the triad proteins depend on the
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Fig. 2. Notch1 is necessary for triad activation. Steady-state concentrations of the triad proteins are plotted as a function of Smad1 phosphorylation rate, (kp), a proxy for
Bmp4 signal (panels A and B). Red, blue and green curves represent the steady-state concentrations of Scl, Gata2 and Fli1, respectively. Solid and dashed lines represent the
stable and unstable states, respectively. Grey areas represent the region where the triad is bistable and can exist in either LOW or HIGH concentrations. (A) In the presence of
Notch1, the triad LOW state only exists when Bmp4 signal is below a certain threshold (knp). Signals above the threshold (kp4knp) irreversibly switch the triad to HIGH state
(shown by arrow). In this and other ﬁgure panels HIGH and intermediate Scl concentrations represent HSPC (Hematopoietic Stem and Progenitor Cell) and HE (Hemogenic
Endothelium), respectively. (B) Black curve shows the dependence of knp on [Notch1]. Below this curve the triad is bistable, whereas above it the triad is monostable and can
only exist in the HIGH state. Note that at very low [Notch1] the triad is always bistable. The blue dot shows the operating point [Notch1]¼1 used in panel A. The red dot
denotes the amount of Notch1 that can activate the network in the absence of a Bmp4 signal. (C) In the absence of Notch1, the triad can exist in either HIGH or LOW states,
both of which exist and are stable for all values of the Bmp4 signal. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version
of this article.)
J. Narula et al. / Developmental Biology 379 (2013) 258–269260signal levels. In our model the Smad1 phosphorylation rate (kp) is
used as a proxy for Bmp4 signaling (Kretzschmar et al., 1997),
whereas Notch1 signaling is modeled explicitly as the binding of
Notch1 to the Gata2 promoter site (Robert-Moreno et al., 2005).
We ﬁnd that the triad module is irreversibly bistable (Fig. 2) which
is in line with our previous results (Narula et al., 2010). As a result,
for a range of Notch1 and Bmp4 signals the triad can exist in one of
two expression regimes: low expression (LOW) or high expression
(HIGH) of all three triad genes. In both regimes, steady state
expression levels of triad genes increases with increase in Notch1
and Bmp4 signal levels (Fig. 2A). In the presence of Notch1, the
LOW state only exists when the Bmp4 signal is below a certain
threshold (Fig. 2A, grey area). In this region the system is bistable,
whereas outside (Fig. 2A, white area) the system is monostable
and can exist only in the HIGH state. Therefore, increasing the
Bmp4 signal irreversibly switches the triad from LOW to HIGH
(indicated by arrow in Fig. 2A). The multiple positive feedback
loops in the triad maintain it in the HIGH state even after the
signals (Bmp4 and/or Notch1) are removed. This again is in accord
with our previous results (Narula et al., 2010). It should be noted
that due to the multiple cooperative interactions between the
triad genes, at steady state all three triad gene are predicted to
simultaneously be either in the LOW or HIGH expression states.
Although it not known what level of triad gene expression is
required to facilitate the transition of a pre-hemogenic endothelial
cell to a hemogenic endothelial (HE) cell we assume here that the
irreversible switch from triad LOW to triad HIGH is not required
for this transition and the increase in LOW state triad expression in
response to Bmp4 is sufﬁcient for transition to HE (Fig. 2A).
Moreover, we believe that the irreversible switch that occurs past
a threshold level of Bmp4 signal (hereafter referred to as the
activation threshold, knp) represents the transition of HE cells to
Hematopoeitic Stem/Progenitor cells (HSPCs).
The model predicts that the Bmp4 signal threshold for triad
activation (knp) depends on the level of Notch1 (Fig. 2B, black
curve). Increasing Notch1 lowers this activation threshold. For the
parameter values used in the model, ﬁnite amounts of Notch1
result in triad activation even in the absence of Bmp4 signal
(Fig. 2B, red dot). Thus, the model predicts that signiﬁcant over-
expression of Notch1 can lead to triad activation even in the
absence of Bmp4 signal. On the other hand, decreasing Notch1
below a certain level causes the activation threshold to approach
inﬁnity, thereby making the activation impossible in the absence
of Notch1. Fig. 2C shows that in the absence of Notch1 the triad isalways bistable, i.e., both HIGH and LOW states exist, regardless of
the Bmp4 signal level. As a result, while Bmp4 can cause an
increase in triad gene expression it is impossible to switch the cells
that start in the triad LOW state to HIGH state by increasing Bmp4
signal in Notch1 mutants. This prediction is consistent with the
observation that blood progenitor emergence does not occur in the
Notch1-null embryo proper (Hadland et al., 2004; Kumano et al.,
2003).The model explains accelerated emergence of HSCs in Runx1
heterozygotes
Next we analyze the role of Runx1 in triad activation. In the
Runx1-null mutant (Runx1−/−) the triad is bistable (Fig. 3A), and as
with the Notch1-null mutant (Fig. 2C) both LOW and HIGH states
exist regardless of the Bmp4 signal level. As a result, while Bmp4
can increase triad gene expression and lead to the appearance of
the hemogenic endothelium (HE), it cannot cause the irreversible
transition to HIGH state (HSPC) and cells remain stuck in the HE
stage. This effect is related to Runx1's ability to enhance the
transcription of triad genes by forming a nuclear complex with
their regulator pSmad1 (Zaidi et al., 2002).
We further explore the effect of Runx1 on the triad in Fig. 3B by
examining how activation threshold (knp) changes with the max-
imum Runx1 production rate (vor ). As expected from Fig. 3A, Bmp4-
mediated triad activation is not possible if the Runx1 production
rate is below a minimum level (see Fig. S2). Increasing production
rate above this minimal level has a non-monotonic effect (i.e. both
increasing and decreasing) on the activation threshold. In this case
the effect is ﬁrst decreasing, then increasing and ﬁnally again
decreasing (black–green–blue curve, Fig. 3B). This is a consequence
of the contrasting roles that Runx1 plays in modulating triad
activation—positive via complex formation with pSmad1 and
negative via upregulation of Smad6. Initially, increasing Runx1
production rate decreases the activation threshold (black branch,
Fig. 3B) due to the cooperative effect of Runx1 on pSmad1's up-
regulation of the triad. However, an opposite trend is observed
later where increasing Runx1 production rate increases the activa-
tion threshold (green branch, Fig. 3B) due to Runx1's negative
effect on pSmad1 via up-regulation of Smad6-mediated degrada-
tion. Further increasing Runx1 production makes its level high
enough to sequester all of Smad6, thereby saturating the negative
effect on pSmad1. As a result, increasing Runx1 production rate
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Fig. 3. The role of Runx1 in triad activation. (A) In the Runx1 null mutant (Runx1−/−), the triad is bistable, but Bmp4 signaling is incapable of switching the triad from LOW to
HIGH (HSPC). However triad expression can still increase leading to the appearance of HE. Red, blue, and green curves represent Scl, Gata2 and Fli1 concentrations,
respectively. (B) Activation threshold (knp) changes non-monotonically with increase in the Runx1 production rate (black–green–blue curve). Grey area represents the region
where triad is bistable. Red and green dots denote the activation thresholds for WT (Runx1+/+) and Runx1 haploid mutant (Runx1+/−), respectively. (C) Steady-state response
of triad to Bmp4 signal in WT (Runx1+/+-red curve) and haploid mutants (Runx1+/−-green curve). Only [Scl] is shown for clarity. The activation threshold for haploid Runx1
mutant is ∼1/2 of that for WT. Dashed curves show unstable states. (D) Dynamics of triad activation in response to a step-increase in Bmp4 signal from kp¼0 to kp¼50 h−1.
The dynamics depend on Runx1 gene dosage. The lower activation threshold allows haploid mutant (green curve) to speed-up triad activation by 2 days compared to WT
(red curve). Grey region represents ΔT½Scl90 , the difference in time to reach 90% of [Scl] level in HIGH state. Note that the Runx1 null-mutant only switches to HE in the presence
of the same signal (yellow curve). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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branch, Fig. 3B).
For model simulations, we assume that wild-type Runx1 (WT,
Runx1+/+) production rate lies in the intermediate portion of the
curve in Fig. 3B (red circle). Hence, a reduction in Runx1 produc-
tion rate lowers the activation threshold. This model assumption is
crucial to explain the phenotype observed in Runx1 heterozygous
deletion mutants (Runx1+/−). In Runx1+/− mutants there is a 50%
decrease in Runx1 production rate (green circle, Fig. 3B), due to
which the activation of the triad can occur at a lower Bmp4 signal
threshold (compare knp for red and green circles in Fig. 3B).
Comparing the steady-state triad responses reveal that the activa-
tion threshold for Runx1+/− mutant is ∼1/2 of that for the WT
(Fig. 3C). This decrease greatly affects the dynamics of triad
activation.
Runx1 is known to be essential for HSC emergence, however
surprisingly HSC emergence is accelerated in the Runx1+/−
mutants (Cai et al., 2000; Lacaud et al., 2004). To understand this
difference in the dynamics of HSC emergence between WT and
Runx1+/− mutant we simulate the kinetics of triad LOW-to-HIGH
activation. Speciﬁcally, we study the kinetics of triad activation in
response to a step-up in the Bmp4 signal (kp) to a value exceeding
the WT activation threshold (ﬁve times the value of knp for the red
circle in Fig. 3B). As shown in Fig. 3D, the decrease in the activationthreshold for the Runx1+/− mutant (observed in Fig. 3B and C)
results in much faster activation of the triad. The speed-up in the
activation can be quantiﬁed by ΔT ½Scl90 —the difference in the times
between WT and haploinsufﬁcient mutant at which Scl reaches
90% of its HIGH steady state value. For the chosen parameter
values, ΔT ½Scl90 is about 2 days, which is in quantitative agreement
with the experimental observation that HSC emergence occurs
earlier in Runx1+/− embryos (Cai et al., 2000; Lacaud et al., 2004).
Though the precise value of ΔT ½Scl90 is affected by changes in kinetic
parameters the qualitative effect is robust (Figs. S3 and Text S1) as
it is a consequence of a fundamental property of bistable switches
—critical slowdown in dynamics near ghost steady states (Fontich
and Sardanyes, 2008; Tiwari et al., 2010; Tiwari and Igoshin, 2012).
Runx1 overexpression can compensate for Notch1 deletion
Recent in vitro experiments have shown that artiﬁcially-
induced Runx1 overexpression can rescue deﬁnitive hematopoi-
esis in Notch1 null mutants (Nakagawa et al., 2006). To mimic this
experiment and to understand the relationship between Runx1
and Notch1 in the context of HSC emergence we introduce an
additional Runx1 production term (vrr) in our model (see the
“Methods” section and SI). Simulations show that, similar to
its dependence on vor , the activation threshold k
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vrr (black curve, Fig. 4A). To uncover the consequences of Runx1
overexpression, we ﬁx vor at the level shown in Fig. 3B and choose
a high vrr (¼100 h−1). We ﬁnd that this level of Runx1 over-
expression allows the triad to be activated by Bmp4 signal alone
([Notch1]¼0 results in ﬁnite knp in Fig. 4B; compared to Fig. 2B).
Therefore, our model explains the observation in Nakagawa et al.
(2006) that artiﬁcially-induced Runx1 overexpression rescues
deﬁnitive hematopoiesis in Notch1-null mutants by reducing the
activation threshold to physiologically relevant levels.
Timing of Runx1 conditional deletion or Smad1 overexpression
determines triad activation dynamics
Several studies have used Cre-mediated recombination and
induced overexpression to highlight the dynamical roles of the
Bmp4-signaling circuit components Smad1 and Runx1 in deﬁni-
tive hematopoiesis (Chen et al., 2009; Lacaud et al., 2002; Tanaka
et al., 2012; Zafonte et al., 2007). In particular, these studies have
shown that (i) Runx1 is only essential up to a certain stage in HSC
emergence and can be conditionally deleted after this stage with-
out compromising HSC maintenance (Chen et al., 2009; Lacaud
et al., 2002) and (ii) transiently induced artiﬁcial overexpression of
Smad1 expands hematopoietic progenitor populations only in a
speciﬁc time-window of HSC emergence (Zafonte et al., 2007).
These studies shed light on previously unknown dynamical
properties of the regulatory system controlling hematopoiesis,
however, the mechanistic underpinnings of the transient roles of
Runx1 and Smad1 remain unexplained. We use our model to show
that these transient roles are the result of the dynamical char-
acteristics of the irreversible bistability in the triad.
First, we address the recent observations that only transient
expression of Runx1 is required for HSC emergence (Chen et al.,
2009; Lacaud et al., 2002; Tanaka et al., 2012). In Chen et al.
(2009), Runx1 was conditionally deleted at different stages of early
embryonic development, and it was found that if this deletion
occurs sufﬁciently early, HSCs never emerge (Chen et al., 2009).
However, if Runx1 was conditionally deleted later in the develop-
mental process HSC emergence is unaffected. Similar temporal and
cell state requirements for Runx1 were observed using different
techniques in other studies, including recent work demonstrating
that Runx1 activity is required at E7.5, four days prior to HSC
emergence at E11 (Lacaud et al., 2002; Tanaka et al., 2012). To
explain these experiments we simulate the activation of the triad
(only Scl shown in Fig. 5A) to a step-increase in Bmp4 signal andthen decrease the Runx1 production rate to zero at different times
(12 h, 24 h,. etc). Our model shows that if Runx1 is knocked out
after triad proteins reach sufﬁcient levels for self-activation, there
is negligible impact on the triad's steady state or dynamic behavior
(Fig. 5A and Fig. S4). This is a consequence of the characteristic
property of irreversibly bistable switches that they only require
transient activation to switch to the HIGH state. Once the triad
proteins reach sufﬁcient levels (the region of attraction for the
HIGH state), the positive feedback loops in the triad forces the
system to quickly reach the HIGH state irrespective of the signal
level. Our model shows a distinct time threshold of about 3.5 days,
thereby deﬁning how long Runx1 expression is necessary for triad
activation and hence HSC emergence (Fig. 5B and Fig. S4). There-
fore, our model is able to quantitatively capture the transient
requirement of Runx1 during HSC emergence (Chen et al., 2009).
The effects of a pulse of Smad1 overexpression on the dynamics
of hematopoietic progenitor cell emergence in vitro has been
recently described (Zafonte et al., 2007). The results indicated that
this effect depends non-monotonically on the timing of the Smad1
overexpression pulse. We simulate this experiment in silico by
including an additional Smad1 production term (rate of produc-
tion −0.1 h−1) in our model equations. Consistent with the experi-
mental protocol, this additional production is only active for a 6-h
period starting at a speciﬁc time-point in the simulation. Under
these modiﬁcations, we vary the time of Smad1 overexpression
pulse and analyze the triad activation dynamics in response to a
step-increase in Bmp4 signal. Fig. 5C shows the Scl activation
dynamics in the presence (black, green and yellow curves) and
absence of pulses (red curves). Blue bars depict the Smad1 pulse
timing. The difference in time to reach 90% of the ﬁnal Scl
concentration with and without a pulse, ΔT ½Scl90 , is denoted by grey
regions. Our model shows that early (∼day 0—top panel) and late
pulses (∼day 4—bottom panel) have small effects on triad activa-
tion dynamics whereas a pulse of Smad1 around day 2 (middle
panel) considerably speeds-up Scl activation (Fig. 5C). This non-
monotonic dependence of triad activation speed-up (ΔT ½Scl90 ) on the
timing of the Smad1 pulse (Fig. 5D) could explain why Smad1
pulses only expand the hematopoietic progenitor population
within a limited developmental time window (Zafonte et al.,
2007). This non-monotonic dependence is a consequence of the
characteristic slow-down in switching dynamics of a bistable
switch. Bistable systems are known to slow-down in a critical
concentration range during a switch between states (Fontich and
Sardanyes, 2008; Sciammas et al., 2011). The coordination of a
Smad1 pulse with the time at which the triad reaches the critical
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Fig. 5. Timing of Runx1 conditional deletion or Smad1 overexpression determines whether Triad activation is affected or not. (A) Scl dynamics with different timings of
Runx1 conditional deletion. Each black circle denotes the time in the trace at which Runx1 production is reduced to zero. Brown curves show Scl dynamics for systems that
fail to activate due to Runx1 conditional deletion, whereas red curves represent activated systems. Switch to HIGH state of the triad with Bmp4 signaling is impossible if
Runx1 is deleted early; however, cells can still increase Scl expression and reach the HE stage. Runx1 deletion after a certain time has negligible effect on triad activation
dynamics or ﬁnal steady state. (B) Steady-state Scl concentration as a function of the time of Runx1 conditional deletion. Early Runx1 deletion interferes with triad activation
and cells cannot fully upregulate Scl; however, Runx1 deletion after day 3.5, has no effect on triad activation. (C) Scl dynamics with different timing of a Smad1
overexpression pulse. Smad1 is overexpressed at a rate of 0.1 h−1 for a 6 h time-window at speciﬁc times during triad activation. Red trajectories show Scl dynamics without
Smad1 overexpression. Blue bars indicate the times of Smad1 overexpression for other trajectories. Note that overexpression around day 2 (middle panel) speeds-up triad
activation the most, whereas both early and late overexpression have less prominent effects (top and bottom panels). Grey region represents the difference in time to reach
90% of the ﬁnal [Scl], ΔT ½Scl90 , with and without the pulse. (D) Speed-up of triad activation ΔT
Scl½ 
90 , depends non-monotonically on the time of Smad1 overexpression. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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dynamics. However due to the small pulse duration, pulses that
are timed to occur before the triad reaches this region have little
effect on the overall time to reach the steady state. Pulses that
come after the triad has passed the slow-down have already been
delayed in the critical region and again the contribution to
activation time is expected to be small.
Novel predictions about the roles of Runx1 and Smad6 in HSC
emergence
Based on the non-monotonic relationship between Runx1
expression rate and triad activation threshold (see Fig. 3B) we
can make several predictions about the roles of Runx1 and Smad6
in this master-regulatory circuit controlling HSC emergence. Our
model predicts that unlike the WT, in Smad6-null mutants the
dynamics of HSC emergence will be identical in Runx1+/− and
Runx1+/+ backgrounds (see Fig. S5A–C). In addition, we predict
that stabilization of p-Smad6 activity by inhibiting its proteasomal
degradation by Bortezomib (Mukherjee et al., 2008) wouldneutralize the proteolytic effect of Smad6 on Runx1 thereby
reducing the difference between HSC emergence dynamics in
Runx1+/+ and Runx1+/− mutants (see Fig. S5D and E). Finally, we
note that, relative to WT, a mutant with three copies of Runx1 is
predicted to increase Smad6 expression and consequently the
triad activation threshold. As a result, HSC emergence in triploid
Runx1 mutants is expected to be slower than both WT and
Runx1+/− mutants (Fig. S5F).Discussion
We have developed a comprehensive model for the network
controlling deﬁnitive blood emergence by combining our previous
model (Narula et al., 2010) of the Scl–Gata2–Fli1 triad with the
Bmp4 signaling module containing Smad1, Smad6 and Runx1. This
framework allows us to systematically assess, analyze and predict
the effects of perturbations on dynamical properties of this net-
work. The model shows that the GRN module under consideration
is irreversibly bistable and can be activated by the combination of
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active even when the signals are removed. If high levels of Scl–
Gata2-–Fli1 gene expression ensure a stable HSC state, the irre-
versible activation of the triad in the AGM could explain why Bmp
signaling later becomes dispensable for the maintenance of HSCs
in the fetal live and adult bone marrow (Singbrant et al., 2010). We
have hypothesized that the irreversible activation of this bistable
switch is not required for the formation of hemogenic endothelial
cells but occurs in HE cells and both contributes to and is
modulated by Runx1 expression which plays a critical role in the
emergence of blood stem/progenitors from the HE. It is important
that this irreversible bistable switch occurs prior to blood cells
emerging from the HE so that maximal expression of these factors,
which are required for down-stream applications, is achieved prior
to cells losing resident cues from their tissues of origin. Based on
this hypothesis, we can compare the predicted dynamical proper-
ties with those observed in various in vivo and in vitro genetic
perturbations of this network.
Our model predicts that Runx1 is essential for deﬁnitive
hematopoiesis in part because it mediates Bmp4 signaling and is
required, albeit only transiently, for the activation of the triad
module. Moreover, the model is able to reconcile this essential
requirement of Runx1 for deﬁnitive hematopoiesis (Lacaud et al.,
2002) with the counter-intuitive observation that heterozygous
deletion of Runx1 actually accelerates HSC emergence (Cai et al.,
2000; Lacaud et al., 2004). We have predicted that this accelera-
tion is connected to the negative effect that Runx1 has on pSmad1
levels via upregulation of Smad6. Due to this negative effect, the
two-fold decrease in the Runx1 production rate that results from a
heterozygous deletion decreases the Bmp4 signal threshold and
thereby accelerates triad activation. Based on our simulations we
also predict that when examined in a Smad6-null mutant back-
ground or in the presence of speciﬁc proteasome inhibitors, there
will be little or no difference in dynamics of HSC emergence
between Runx1+/+ and Runx1+/−.
Additionally, the model predicts that the transient perturba-
tions to the signaling module will affect the activation dynamics
only if they occur sufﬁciently early. Current observations of the
temporal requirement for Runx1 during hematopoietic develop-
ment suggest it is required early, either in the E7.5 extra-
embryonic mesoderm, and/or later in the hemogenic endothelium
(Tanaka et al., 2012). We predict that the conditional deletion of
Runx1 has no effect on triad activation if it occurs after ∼3.5 days
from the onset of the hematopoietic program. We also predict that
pulsed overexpression of Smad1 leads to the expansion of the
hematopoietic progenitor population within a particular time-
window and the magnitude of the expansion depends non-
monotonically on the timing of the Smad1 pulse. These predictions
are in excellent qualitative and quantitative agreement with
recently reported and unexplained experimental observations that
motivated these simulations (Chen et al., 2009; Tanaka et al., 2012;
Zafonte et al., 2007). Moreover, these predictions are robust to the
parameter values used in the model as these dynamical effects are
related to the fundamental mathematical properties of bistable
switches (see Text S1 Figs. S3, S4).
We have also found that these predictions are robust to certain
changes in the dynamics of upstream signaling systems such as
the Notch pathway. While this manuscript was under review, a
new study has shown that Notch signaling is downregulated
during HSC emergence (Richard et al., 2013). By repeating our
simulations for a decreasing Notch1 level (see Text S1), we found
that this change in the dynamics of Notch signaling increases the
minimum Bmp4 signal required to switch the triad to a high
expression HSC state (Fig. S6A and B). However decreasing Notch1
levels do not change our results regarding the earlier emergence of
HSCs in the haploid Runx1+/− mutants (Fig. S6C and D). This showsthat our predictions are qualitatively robust to dynamical changes
in the signaling systems controlling the HSC network.
In our model we have used a statistical thermodynamics
framework (Bintu et al., 2005; Mirny, 2010; Narula et al., 2010)
to model the combinatorial effect of multiple transcription factors
on gene regulation. Following recent experimental evidence
(Knezevic et al., 2011; Narula et al., 2010; Nottingham et al.,
2007; Oren et al., 2005; Pimanda et al., 2007a, 2007b), we assume
that transcription factors acting at cis-regulatory elements control
gene expression by increasing the probability of a RNA-polymerase
accessible state of chromatin rather than through direct physical
interactions with polymerase (see the “Methods” section). This no-
contact assumption posits a biophysical mechanism for gene
regulation which is different from the typical TF-RNA polymerase
contact mechanism where DNA looping is assumed (Bintu et al.,
2005). However, mathematically the two approaches are inter-
convertible (see the “Methods” section) and the no-contact
mechanism dramatically reduces the number of free model para-
meters and thereby enhances the utility of this approach when
data is limited.
The heterogeneity of assays and functional readouts of deﬁni-
tive blood development limits the direct comparisons between
model predictions and experimental data. Nevertheless we have
demonstrated that predictions from our model are consistent with
experimental observations. Altogether our model shows that the
temporal inﬂuence of Runx1 and mediators of the Bmp4 signaling
pathway on the emergence of HSCs and progenitor cells can be
explained by their effects on the activation dynamics of the Scl–
Gata2–Fli1 triad. Such an integrative view of the GRN controlling
deﬁnitive blood cell emergence offers a way to consolidate
information from an array of genetic perturbation experiments.
Nevertheless it should be noted that while this model reﬂects and
explains current knowledge of HSC emergence in the AGM it will
require updating to accommodate future advances in our knowl-
edge. However, as Fig. S6 demonstrates, our qualitative predictions
can be robust to the incorporation of newly discovered features of
signaling dynamics (Richard et al., 2013) whereas some quantita-
tive predictions remain sensitive to these changes.
Our model also enables us to generate hypotheses about the
roles of network components and connections. For instance, our
observation that higher Runx1 production rates lead to slower
emergence (Fig. 3D), may indicate that Runx1 plays a role in the
temporal order of stem/progenitor emergence from hemogenic
endothelium during embryonic development, i.e. progenitors with
restricted lineage potential preceding emergence of deﬁnitive
HSCs.
Although required for deﬁnitive HSC production, neither Runx1
nor Notch1 is essential for primitive erythroid development,
whereas components of the triad such as Scl are required for both
(Lacaud et al., 2002; Robb et al., 1995; Shivdasani et al., 1995). Our
view is that activation of the triad to the HIGH state may not be
essential for primitive hematopoiesis. As such, expression of
components of the triad (such as Scl) which are required for this
process can occur without activation of the triad to the HIGH state.
In this context, our model shows that although Runx1 and Notch1
are essential for switching the triad to the HIGH expression state
of the HSCs, Bmp4 can lead to increased expression of triad
components in their absence (Fig. 3A).Conclusion
Despite much advancement in our understanding of how HSCs
are formed in the embryo, translating this knowledge into novel
protocols for the in vitro production of HSCs has proved difﬁcult
due to the complexity of the network architecture that control this
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computational approaches are a useful adjunct to integrating
experimental data and help interpret previously unexplained
biological observations on dynamical network properties. The
model proposed here suggests two issues that may inﬂuence
future protocol design; the ﬁrst is the importance of signal path-
way combinatorial activity, demonstrated by the complementary
roles of Notch1 and Bmp4; and the second is the vital role of
negative regulators such as Smad6 in ﬁne-tuning the levels of key
transcription factors (also relevant given the recent ﬁndings
describing a Notch, Hes1 and Gata2 network with negative feed-
back (Guiu et al., 2013)). Both issues could inform how the
duration and combination of exogenous stimulation of key signal-
ing pathways is considered when developing future HSC produc-
tion protocols.Methods
Mathematical model for the gene regulatory network containing triad
and signaling modules
To uncover the role of Runx1, Smad1 and Smad6 in hematopoi-
etic stem cell (HSC) emergence we use an ordinary differential
equation (ODE) based deterministic model. This model is based on
known transcriptional and post-translational interactions (see
Fig. 1) and previously published experimental characterizations
of the various cis-regulatory interactions in the network control-
ling HSC emergence in the embryo. These are described in detail in
the following sections.
Thermodynamic modeling of gene regulation
We combine the processes of transcription and translation
involved in the production of a protein from its corresponding
gene into a single synthesis reaction. The rate of this reaction
depends on the combinatorial binding of transcription factors
(TFs) at promoters and enhancers that regulate the expression of
each gene. Further, we assume based on available experimental
results (Pimanda et al., 2007b; Smith et al., 2008) that the increase
in the transcriptional rate occurs via modulation of the state of
chromatin rather than through direct interaction with transcrip-
tional machinery. We call this the No-contact model of transcrip-
tional regulation by cis-regulatory elements (Mirny, 2010; Narula
and Igoshin, 2010; Narula et al., 2010) as opposed to Contact
models where transcription factors act by direct physical interac-
tion with RNA polymerase. Speciﬁcally, the gene of interest can
exist in either a RNA polymerase-accessible (open) chromatin or
RNA polymerase-inaccessible (closed) chromatin state. The bind-
ing of TFs at the enhancer or promoter shifts the equilibrium
towards the open state, thereby increasing the probability of gene
expression. As a result, the probability of transcription can be
approximated by the probability of the open chromatin state. To
determine how this probability depends on the concentrations of
various TFs we use a statistical thermodynamic approach (Mirny,
2010; Narula and Igoshin, 2010; Narula et al., 2010) that allows us
to derive each gene's regulatory function on the basis of known
combinatorial interactions. The parameterization of such a regu-
latory function requires measurements of binding afﬁnities
between DNA and TFs as well as interaction strengths among
TFs. This entails measuring the contribution of each TF to the
transcriptional rate, both individually as well as in every possible
combination with other TFs. It is extremely difﬁcult to measure all
these contributions due to the combinatorial multiplicity of TF
conﬁgurations at enhancers and promoters in eukaryotic systems,
and as a result such information does not exist for most systems.Instead, experimental data typically includes quantiﬁcation of the
effect of mutation of speciﬁc TF binding sites on the expression
rates from a luciferace or lacZ reporter (Narula et al., 2010;
Pimanda et al., 2007b). Previously, we have shown that such
measurements can be used to estimate the strengths of TF–TF
and TF–DNA interactions by using appropriate normalization for
TF concentrations (Narula et al., 2010). Here we use the same
methods to model the GRN in Fig. 1 and to estimate the various
parameters. Below we provide the various regulatory functions
and estimated parameter values, however we refer the reader to
Narula and Igoshin (2010), Narula et al. (2010) for details of this
method and provide the regulatory functions and parameters used
in our model below.
Relationship between no-contact and contact models
of transcriptional regulation
Consider a gene Y regulated by the combinatorial action of
multiple activating TFs Xi (i∈1,2,…,n) at a cis-regulatory region. In
the no-contact model (see Narula and Igoshin, 2010 for a detailed
derivation), the transcription rate of Y can be written in terms of
the concentrations of Xis:
vY ¼ voY
zY
ðKY þ zY Þ
;
zY ¼ 1þ ∑
n
i ¼ 1
½Xie−Gi þ ∑
n
i ¼ 1
∑
n
j ¼ 1
½Xi½Xje−Gij þ⋯ ð1Þ
where voY is the maximum rate of expression of gene Y, KY is the
equilibrium constant of chromatin remodeling, [Xi] is the concen-
tration of TF i, and Gi is the binding free energy of TF i. The fraction
zY/(KY+zY) is the probability of the RNA-polymerase accessible
state of chromatin and its exact form is determined by the
partition function zY which sums over all the possible TF-bound
states of the regulatory region. In this model we assume that TFs
only control the probability of the polymerase accessible state of
chromatin at the promoter and therefore the rate of transcription
is proportional to the probability of ﬁnding DNA in one of the
accessible conformations. In this mechanism, regulation of tran-
scription by TFs does not require their physical interaction with
RNA polymerase. However, as shown below, the regulatory func-
tion of this No-contact mechanism (Eq. (1)) can be rewritten in a
form similar to regulatory functions for a contact mechanism of
gene regulation where TFs do interact with RNA polymerase.
Dividing both numerator and denominator in Eq. (1) by KY+1
we obtain,
vY ¼
voY
KY þ 1
1þ∑ni ¼ 1½Xie−Gi þ∑ni ¼ 1∑nj ¼ 1½Xi½Xje−Gij þ⋯
1þ∑ni ¼ 1 Xi½  e
−Gi
KYþ1 þ∑ni ¼ 1∑nj ¼ 1 Xi½  Xj
 
e−Gi
KYþ1 þ⋯
ð2Þ
The above equation can be rewritten as
vY ¼ vbasalY
1þ∑ni ¼ 1f ½Xie−G′i þ∑ni ¼ 1∑nj ¼ 1f ½Xi½Xje−G′ij þ⋯
1þ∑ni ¼ 1½Xie−G′i þ∑ni ¼ 1∑nj ¼ 1½Xi½Xje−G′ij þ⋯
ð3Þ
where
vbasalY ¼
voY
KY þ 1
; G′i ¼ Gi þ logðKY þ 1Þ and f ¼ KY þ 1;
Here the fold-change f can be interpreted as the maximum
increase in transcription rate resulting from the binding of each TF
or TF complex. Eq. (3) resembles the typical cis-regulatory function
derived in the contact models of combinatorial transcription
regulation where TFs directly interact with RNA polymerase
(Bintu et al., 2005). As seen from Eqs. (2) and (3) the contact
and no-contact models are mathematically equivalent even
though they represent different biophysical mechanisms of gene
regulation. However, in the contact model the fold-changes
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different but Eqs. (2) and (3) are only mathematically equivalent
only under the assumption of equal fold-changes. It should be
noted though that the experimental data that is generally available
(measurements of lacZ expression from deletion libraries of cis-
regulatory elements) is usually insufﬁcient to simultaneously
determine the fold-changes and binding free-energies of TFs and
TF complexes (Narula and Igoshin, 2010; Narula et al., 2010).
Therefore, we believe that using the no-contact model with its
implicit assumption of equal fold-changes is a reasonable approx-
imation. This formulation (Eq. (1)) is used throughout the follow-
ing sections to derive the cis-regulatory functions of various genes
in our model.
Notation
The notation used throughout these Methods is summarized in
Table S1. Brackets [    ] denote concentrations. Note that all
concentrations are in dimensionless units and are assumed to be
normalized by their steady-state values in the absence of Bmp4
and Notch1 signals. In addition, Gxy, denotes a free energy of
binding of TF x to an enhancer of gene y.
Triad transcriptional regulation
The triad genes Scl, Gata2 and Fli1 regulate each other by acting at
the Scl+19, Gata2–3 and Fli1+12 enhancers (Pimanda et al., 2007b;
Smith et al., 2008). In addition, the Gata2 promoter is known to be
regulated by Bmp4 (via pSmad1) and Notch1 and the Fli1 promoter is
regulated by Bmp4 (via pSmad1). Using available details of TF binding
sites in these of enhancers and promoters we have previously shown
that the following equations can be used to describe the rates of
transcription vs (Scl), vg (Gata2) and vf (Fli1) for the triad:
vs ¼ vos
zs
ðKsþzsÞ
;
zs ¼ 1þ ½Ge−G
g
s þ ½F2e−2Gfs þ ½G½F2e−Ggfs
ð4Þ
vg ¼ vog
ð1þ f 1ð½pS1−R þ α½pS1Þe−G
bp þ f 2½N1Þzg
ðKg þ ð1þ ð½pS1−R þ α½pS1Þe−Gbp þ ½N1ÞzgÞ
;
zg ¼ 1þ ½Ge−G
g
g þ ½F2e−2Gfg þ ½G½F2e−Ggfg þ ½S½G½F2e−Gsgfg
ð5Þ
vf ¼ vof
ð1þ f 1ð½pS1−R þ α½pS1Þe−G
bp Þzf
ðKf þ ð1þ ð½pS1−R þ ½pS1Þe−Gbp Þzf Þ
;
zf ¼ 1þ ½Ge−G
g
f þ ½F2e−2G
g
f þ ½G½F2e−G
gf
f þ ½S½G½F2e−G
sgf
f
ð6Þ
Here, vos , v
o
g and v
o
f are the maximum rates of transcription from
the Scl, Gata2 and Fli1 promoters in the absence of Notch1 and
Bmp4 signals. Ks, Kg and Kf are the equilibrium constants of the
chromatin state of the Scl, Gata2 and Fli1 regulatory regions,
respectively. f1 (¼4) (Lugus et al., 2007) and f2 (¼3.5) (Robert-
Moreno et al., 2005) denote the fold-change in gene expression
rate resulting from the effect of Bmp4 and Notch1 on the
appropriate promoters. Based on Oren et al. (2005), Zaidi et al.
(2002), we have modiﬁed Eqs. (4)–(6) from those in Narula et al.
(2010) to specify that Bmp4 affects Gata2 and Fli1 expression via
the binding of pSmad1 and pSmad1:Runx1 complex. We assume
based on the observations of Zaidi et al. (2002) that the pSmad1:
Runx1 complex is more effective than pSmad1 alone at increasing
the transcription from Gata2 and Fli1 promoters. Accordingly, we
assume that pSmad1 alone can only effect a fold-change αf1 where
αo1. [N1] represents the concentration of Notch1 acting on the
Gata2 promoter normalized by its dissociation constant of binding
to the promoter. The parameters used in Eqs. (4)–(6) were derivedin Narula et al. (2010) based on the results from Gottgens et al.
(2002), Pimanda et al. (2007b) and are reproduced in Table S2.
Smad1 transcriptional regulation
Gene expression from the Smad1 promoter is regulated by the
Smad1–7 upstream enhancer. This enhancer includes multiple Fli1
(Ets) binding sites as well as a Gata2 binding site (Fig. S1 and data
not shown). We assume that this enhancer modulates Smad1
transcription by controlling the probability of transcription from
the Smad1 promoter. Following this assumption and the deletion
analysis of the Smad1–7 enhancer (Fig. S1) the rate of Smad1
transcription, vs1, was modeled using the following equation:
vs1 ¼ vos1
zs1
Ks1 þ zs1
;
zs1 ¼ ð1þ ½F2e−2G
f
s1 Þð1þ ½Fe−Gf ′s1 Þð1þ ½Ge−Ggs1 Þ
ð7Þ
Here, vos1 is the rate of transcription from the Smad1 promoter
and Ks1 is the equilibrium constant of the chromatin state of the
Smad1 regulatory region. Using lacZ-reporter expression assay
data (not shown) we have determined the various free energies in
Eq. (7) in terms of the Ks1. The parameter values used in model for
the Smad1–7 enhancer are given in Table S3.
Smad6 transcriptional regulation
Smad6 expression is regulated by the Smad6 promoter as well
as the upstream Smad6–57 enhancer (Fig. S1). Both the promoter
and enhancer include binding sites for the triad proteins as well as
Runx1 and pSmad1. We assume that this enhancer modulates the
probability of transcription whereas the promoter controls the rate
of Smad6 transcription. Following these assumptions and the
deletion analysis of the Smad6 enhancer and promoter (Knezevic
et al., 2011; Pimanda et al., 2007a), the rate of Smad6 transcription,
vs6, was modeled using the following equation:
vs6 ¼ vos6
zs6p
ðKs6p þ zs6pÞ
zs6e
ðKs6e þ zs6eÞ
;
zs6p ¼ ð1þ ½F2e−2G
f
s6p Þð1þ ð½R þ ½pS1−RÞe−Grs6p Þð1þ ½S2½G½F2e−G
sgf
s6p Þ;
zs6e ¼ 1þ ½Re−G
r
s6e ð1þ ½Ge−Ggs6e Þ
ð8Þ
Here, vos6 is the maximum rate of transcription from the Smad6
promoter and Ks6p and Ks6e are the equilibrium constants of the
chromatin state of the Smad6 promoter and enhancer, respec-
tively. Using the data from (Knezevic et al., 2011; Pimanda et al.,
2007a) we can determine the various free energies in Eq. (8) in
terms of Ks6p and Ks6e. The parameter values used in model for the
Smad6 regulation are given in Table S4.Runx1 transcriptional regulation
Runx1 expression is regulated by the two promoters P1 and P2
as well as the intronic Runx1+23 enhancer (Fig. S1; (Bee et al.,
2009a, 2009b; Nottingham et al., 2007; Pimanda et al., 2007a)).
These promoters and enhancer include binding sites for the triad
proteins as well as Runx1 and pSmad1. It has been shown that the
Runx1+23 enhancer speciﬁcally directs gene expression from both
promoters in hemogenic tissue (Bee et al., 2009a). Moreover Runx1
+23 can modulate the gene expression from each promoter
independent of the other (Bee et al., 2009b). It has also been
recently shown that transcription from promoter P1 largely
depends on the binding of Runx1 and pSmad1 rather than triad
proteins (Bee et al., 2009a). We again assume that the enhancer
modulates the probability of transcription whereas the promoters
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assumptions into account and using the deletion analyses of the
Runx1 enhancer and promoters (Bee et al., 2009a, 2009b;
Nottingham et al., 2007; Pimanda et al., 2007a), the rate of Runx1
transcription, vs6, was modeled using the following equation:
vr ¼ vor
zrp1
Krp1 þ zrp1
þ zrp2
Krp2 þ zrp2
 
zre
ðKre þ zreÞ
;
zrp1 ¼ 1þ ½pS1−Re−G
ps1
rp1 ; zrp2 ¼ 1þ ½F2e−2G
f
rp2 ;
zre ¼ 1þ ½R½Ge−G
rg
re ð1þ 2½Fe−Gf ′re þ ½F2e−2Gfre Þ
ð9Þ
here, vor is the maximum rate of transcription from the Runx1
promoter and Krp1, Krp2 and Kre are the equilibrium constants of
the chromatin state of the promoters P1 and P2 and the Runx1+23
enhancer, respectively. We assume the same vor for both promoters
since transcription from both promoters has been shown to be
comparable (Bee et al., 2009a). Using the data from Bee et al.
(2009a, 2009b), Nottingham et al. (2007), Pimanda et al. (2007a),
we can determine the various free energies in Eq. (9) in terms of
Krp1, Krp2 and Kre. The parameter values used in model for the
Runx1 regulation are given in Table S5. vor was multiplied by 0,
0.5 and 1.5 to model mutations such as Runx1−/−, Runx1+/− and
three copies of Runx1, respectively.Protein degradation/dilution
We assume that the rate of degradation for all model species
follows ﬁrst-order kinetics. Degradation rates kideg for each species
i in the model were calculated based on experimental data about
protein stability (Yen et al., 2008). We used a half-life of 24 h for
Scl, 4 h for Fli1 and 2 h for the remaining species (Gata2, Smad1,
pSmad1, Runx1, Smad6, pSmad1:Runx1, pSmad1:Smad6 and
Runx1:Smad6).Post-translational reactions
The Bmp4 signaling network includes many post-translational
interactions involving the regulatory Smads, Smad1 as well as the
inhibitory Smad, Smad6 (Hata et al., 1998; Murakami et al., 2003;
Zhang et al., 2001). Phosphorylation of Smad1 by Bmp4 bound
receptors leads to the formation of pSmad1 which translocates
into the nucleus and affects gene expression of Bmp4 signaling
target genes (Hata et al., 1998). Smad6 inhibits Bmp4 signaling by
(i) binding to Bmp4 bound receptors and targeting them degrada-
tion (Hata et al., 1998), (ii) binding pSmad1 and inhibiting its
translocation into the nucleus (Hata et al., 1998) and (iii) binding
pSmad1 and facilitating Smurf-mediated ubiquitination and sub-
sequent proteosomal degradation of pSmad1 (Murakami et al.,
2003; Zhang et al., 2001). We assume, for simplicity, that primary
inhibitory effect of Smad6 on pSmad1 is the Smurf-mediated
degradation of pSmad1. Runx1 can participate in Bmp4 signaling
by binding to pSmad1 in the nucleus and affecting its transcription
factor activity (Zaidi et al., 2002). Moreover Smad6 can bind to
Runx1 and target it to the proteasome similar to its effect on
pSmad1 (Shen et al., 2006). We include the following post-
translational reactions in our model to reﬂect a simpliﬁed version
of the Bmp4 signaling pathway and Runx1's interaction with
Smads. Bmp4 binds to a cell-surface receptor leading to the phosphor-
ylation of the regulatory Smad Smad1 (Larsson and Karlsson,
2005; Paulsen et al., 2011). We model the phosphorylation of
Smad1 as a simple ﬁrst-order reaction and use the rate ofphosphorylation, kp, as a proxy for the Bmp4 dose.
Smad 1⟹
kp
pSmad 1 ð10Þ Smad1 localization in the nucleus has been shown to be Runx1
dependent (Zaidi et al., 2002). In our model, we assume that
Runx1 binds, reversibly, to phosphorylated Smad1 (pSmad1)
and that this complex can affect transcriptional regulation
(Zaidi et al., 2002).
pSmad1 þ Runx1⇌kb1
kd1
pSmad1−Runx1 ð11Þ Smad6 binds to pSmad1 and Runx1 to form complexes that are
targeted for Smurf-mediated proteolytic degradation (Hata
et al., 1998; Murakami et al., 2003; Zhang et al., 2001).
Proteolytic degradation is modeled as a ﬁrst-order reaction.
pSmad1þ Smad6 ⇌kb
kd
pSmad1−Smad6⟹
kprot
∅ ð12Þ
Runx1þ Smad6 ⇌kb
kd
Runx1−mad6⟹
kprot
∅ ð13Þ We also include a partner-switching reaction in which Smad6
replaces Runx1 in the pSmad1–Runx1 complex. The resulting
pSmad1–Smad6 is targeted for proteolytic degradation as above.
pSmad1−Runx1þ Smad6⟹kb pSmad1−Smad6þ Runx1 ð14Þ
pSmad1−Smad6⟹
kprot
∅ ð15Þ
The parameter values for all post-translational reactions are
given in Table S6. To model the effect of proteosomal inhibition
by Bortezomib (BTZ) the proteolytic degradation rate, kprot, was
set to zero.
Model equations
All model details are used to derive the following system of
ODEs that describe the GRN under consideration:
d½S
dt
¼ vs−kSdeg S½ 
d½G
dt
¼ vg−kGdeg G½ 
d½F
dt
¼ vf−kFdeg F½ 
d½S1
dt
¼ vs1−kp S1½ −kS1deg S1½ 
d½pS1
dt
¼ kp S1½ − pS1½ ðkb S6½  þ kb1 R½ Þ þ kd pS1−S6½ 
þkd1½pS1−R−kS1deg ½pS1
d½S6
dt
¼ vs6−kb S6½ ð pS1½  þ R½  þ pS1−R½ Þ þ kdð pS1−S6½ 
þ½R−S6Þ−kS6deg ½S6
d½R
dt
¼ vrr þ vr− R½ ðkb S6½  þ kb1 pS1½ Þ þ kd R−S6½  þ kd1 pS1−R½ 
þkb½pS1−R½S6−kRdeg½R
d½pS1−S6
dt
¼ kb S6½ ð pS1½  þ pS1−R½ Þ−kd pS1−S6½ −kprot pS1−S6½ 
−kS1deg ½pS1−S6
d½R−S6
dt
¼ kb R½  S6½ −kd R−S6½ −kprot R−S6½ −kRdeg R−S6½ 
J. Narula et al. / Developmental Biology 379 (2013) 258–269268d½pS1−R
dt
¼ kb1 R½  pS1½ −kd1 pS1−R½ −kb pS1−R½  S6½ −kS1deg pS1−R½ 
ð16Þ
here vrr in the differential equation for [R] is included to model
Runx1 overexpression (see Fig. 4). vrr was set to 100 h−1 for Fig. 4B.
ODEs for all models (WT and mutants) were solved using the
command-line bifurcation package CL-MATCONT (Dhooge et al.,
2003) to obtain the steady-state signal–response curves (one-
parameter bifurcation diagrams) containing range of signals for
which two different steady states are possible. The package was
also used to obtain the two-parameter bifurcation diagrams which
depict the range of parameter values for which two different
steady states are possible. For all models, dynamics to step-input
in the Bmp4 signal were analyzed using the ode23s solver in
MATLAB 2010a(R) (MathWorks, Natick, Massachusetts). Dimen-
sionless models were used in all simulations.Acknowledgements
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